Omniflo and Transvivo
Omniflo is a subsidiary of Transvivo, which developed the SCIP™ catheter for slow, continuous, intracorporeal plasmapheresis. We have now developed the Omni-DL™ high permeability hemodialysis system. This CRRT treatment platform is compact, highly portable, extremely accurate, and can be used with a wide range of patients. The Omni-DL™ has a sophisticated design, touchscreen interface and highly accurate pumping and sensing algorithms. Please call today to find out more, or click the link below to contact us using the form at OmniFloInc.com.
Contact Omniflo Inc.
